YAZ post-marketing surveillance in Japan
This study is a regulatory post marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received YAZ for dysmenorrhea. The objective of this study is to assess safety and efficacy of using YAZ in clinical practice. A total 3,000 patients will be recruited and followed 3 years since starting YAZ administration.
- Patients who received YAZ for dysmenorrhea Additional criteria for QOL questionnaire - Patient informed consent
- Patients who are contraindicated based on the product label Additional criteria for QOL questionnaire - Six months or less after treatment of estrogen or estrogen combination drug
Many locations, Japan
E-mail: [email protected]
Phone: (+) 1-888-8422937
Drug use investigation of YAZ